Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

EntreMed Grossing $10.25M In Private Financing Transaction

April 28, 2003

By Aaron Lorenzo

EntreMed Grossing $10.25M In Private Financing Transaction

April 28, 2003

By Aaron Lorenzo

High Revenues Drive Earnings Growth At Biotech Bellwethers

April 25, 2003

By Aaron Lorenzo

High Revenues Drive Earnings Growth At Biotech Bellwethers

April 25, 2003

By Aaron Lorenzo

Indevus Licenses Antifungal Compound, Plans Clinical Trials

April 24, 2003

By Aaron Lorenzo

Texas Bio Dissolves ICOS Venture, Regains Full Rights To Sitaxsentan

April 24, 2003

By Aaron Lorenzo

Texas Bio Dissolves ICOS Venture, Regains Full Rights To Sitaxsentan

April 24, 2003

By Aaron Lorenzo

Indevus Licenses Antifungal Compound, Plans Clinical Trials

April 24, 2003

By Aaron Lorenzo

Neurocrine Achieves Long-Term Efficacy Results In Indiplon Trial

April 23, 2003

By Aaron Lorenzo

Neurocrine Achieves Long-Term Efficacy Results In Indiplon Trial

April 23, 2003

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...